LPL Financial LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$33,618,053
+2.3%
330,042
+1.4%
0.02%
+4.3%
Q2 2023$32,849,495
+19.3%
325,532
+8.7%
0.02%
+9.5%
Q1 2023$27,539,880
-5.5%
299,347
-6.9%
0.02%
-16.0%
Q4 2022$29,154,969
+23.4%
321,373
+3.4%
0.02%
+8.7%
Q3 2022$23,617,000
-14.0%
310,714
-4.3%
0.02%
-11.5%
Q2 2022$27,457,000
+12.1%
324,820
+16.4%
0.03%
+23.8%
Q1 2022$24,496,000
+11.8%
279,162
+11.4%
0.02%
+16.7%
Q4 2021$21,913,000
+0.7%
250,516
-5.9%
0.02%
-10.0%
Q3 2021$21,766,000
-9.7%
266,150
+0.8%
0.02%
-16.7%
Q2 2021$24,099,000
+5.4%
264,123
-1.3%
0.02%
-7.7%
Q1 2021$22,870,000
-11.1%
267,547
-1.8%
0.03%
-21.2%
Q4 2020$25,727,000
+37.3%
272,446
+26.5%
0.03%
+13.8%
Q3 2020$18,731,000
-2.5%
215,403
-2.0%
0.03%
-12.1%
Q2 2020$19,202,000
+12.5%
219,857
+6.2%
0.03%
-10.8%
Q1 2020$17,065,000
-8.2%
206,979
+5.5%
0.04%
+8.8%
Q4 2019$18,586,000
+14.7%
196,281
+5.2%
0.03%
+3.0%
Q3 2019$16,211,000
+3.7%
186,544
+9.0%
0.03%0.0%
Q2 2019$15,627,000
+8.9%
171,144
+14.7%
0.03%0.0%
Q1 2019$14,344,000
+20.4%
149,201
+7.5%
0.03%
+3.1%
Q4 2018$11,914,000
+5.1%
138,840
+5.5%
0.03%
+18.5%
Q3 2018$11,341,000
+24.0%
131,627
+8.8%
0.03%
+12.5%
Q2 2018$9,143,000
+2.5%
121,029
+9.7%
0.02%
-4.0%
Q1 2018$8,916,000
+9.3%
110,279
+13.5%
0.02%0.0%
Q4 2017$8,157,000
+6.5%
97,153
+8.9%
0.02%
-7.4%
Q3 2017$7,660,000
+17.3%
89,234
+14.0%
0.03%
+8.0%
Q2 2017$6,533,000
+441.7%
78,269
+382.5%
0.02%
+212.5%
Q1 2017$1,206,000
-3.0%
16,221
-5.0%
0.01%
-11.1%
Q4 2016$1,243,000
+69.8%
17,068
+83.8%
0.01%
+28.6%
Q3 2016$732,000
-0.8%
9,286
+3.2%
0.01%
+16.7%
Q2 2016$738,000
-95.3%
8,998
-95.8%
0.01%
-86.0%
Q1 2016$15,621,000
-10.5%
215,161
+6.3%
0.04%
-10.4%
Q4 2015$17,457,000
+58.3%
202,490
+73.0%
0.05%
-21.3%
Q3 2015$11,029,000
+0.7%
117,080
+5.4%
0.06%
+8.9%
Q2 2015$10,951,000
-0.7%
111,043
+0.5%
0.06%0.0%
Q1 2015$11,032,000
-5.6%
110,473
-12.4%
0.06%
-12.5%
Q4 2014$11,692,000
+15.1%
126,177
+15.8%
0.06%
+4.9%
Q3 2014$10,157,000
-7.9%
108,963
-10.6%
0.06%
-4.7%
Q2 2014$11,034,000
-1.0%
121,885
-7.1%
0.06%
-7.2%
Q1 2014$11,150,000
-6.3%
131,151
-11.4%
0.07%
-6.8%
Q4 2013$11,896,000
+12.7%
147,992
+5.4%
0.07%
+5.7%
Q3 2013$10,556,000
+14.5%
140,388
+7.6%
0.07%
+6.1%
Q2 2013$9,222,000130,4240.07%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders